OLIVI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 97
EU - Europa 78
AS - Asia 23
Totale 198
Nazione #
US - Stati Uniti d'America 97
IT - Italia 32
IE - Irlanda 18
SE - Svezia 13
SG - Singapore 12
CN - Cina 5
DE - Germania 5
IN - India 3
UA - Ucraina 3
AL - Albania 2
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
JP - Giappone 1
KR - Corea 1
MD - Moldavia 1
UZ - Uzbekistan 1
Totale 198
Città #
Chandler 34
Dublin 18
Turin 11
Nyköping 9
Torino 8
Medford 6
Singapore 6
Milan 4
Princeton 4
Ashburn 3
Chennai 3
Munich 3
Beijing 2
Fairfield 2
Hangzhou 2
Honolulu 2
Rome 2
Tirana 2
Ann Arbor 1
Bolzano 1
Boydton 1
Brno 1
Cambridge 1
Cheyenne 1
Empoli 1
Grottaglie 1
Hamburg 1
Houston 1
Kurume 1
Lappeenranta 1
Los Angeles 1
Nuremberg 1
Rochester 1
Seoul 1
Upper Marlboro 1
Zaragoza 1
Totale 139
Nome #
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia 58
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus Acute Lymphoblastic Leukemia study 48
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study 43
Evolving therapeutic approaches for older patients with acute myeloid leukemia in 2021 33
Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience 10
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax 5
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges 4
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 4
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia 3
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 2
Totale 210
Categoria #
all - tutte 1.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.284


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 6 4 2 0 2 4
2021/202242 0 0 1 1 1 3 0 0 6 5 15 10
2022/202392 8 11 1 11 7 28 4 4 8 2 6 2
2023/202453 6 3 9 2 2 6 1 0 2 2 5 15
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 210